However, cancer cells can also evade ferroptosis by utilizing metabolic reprogramming, such as the pyruvate dehydrogenase kinase 4 (PDK4)-mediated inhibition of pyruvate oxidation and fatty-acid synthesis [165]. This evidence concerns the gene PDK4 and cancer.